Introduction {#s1}
============

No current biologic marker exists for sub-classification of obesity in terms of outcome of therapies. Part of the pathophysiology of severe obesity may involve the autonomic nervous system (ANS) \[[@R01], [@R02]\]; previous reports have also implicated enteric abnormalities \[[@R03]\]. In other severe medical conditions involving the ANS and enteric nervous system (ENS), physiologic testing has been useful to predict therapeutic outcomes \[[@R04]-[@R06]\]. Vagal sensory activity has been implicated as part of the hypothalamic and cortico-limbic control helping to regulate energy balance \[[@R07]\]. This mechanism was explored in clinical trials for intra-abdominal vagal nerve blockade for the treatment of obesity \[[@R08]\]. The vagal nerve is part of the ANS which was non-invasively measured by vasoconstriction (VC), postural adjustment ratio (PAR) and R-to-R interval (RRI) in our study. The ENS was measured using cutaneous electrogastrogram (EGG).

The availability of ANS and ENS testing has been important in the identification of specific abnormalities in illnesses with severe organ involvement or failure \[[@R06], [@R9], [@R10]\]. Based on the evaluation of organ failure patients with ANS/ENS testing, we hypothesized that the results might be abnormal in patients with severe obesity.

It has been previously reported that both ANS measures at 1 - 2 years and ENS measures at 4 - 5 years may be helpful in predicting long-term outcomes of surgical therapies for obesity \[[@R11]-[@R19]\]. This study aimed to determine whether an ANS/ENS-based model at baseline and at 3 months postoperatively predicts long-term weight outcome in morbidly obese patients undergoing vertical banded gastroplasty.

Materials and Methods {#s2}
=====================

Thirty-nine morbidly obese patients were studied between 1988 and 1990 before undergoing a restrictive operation - vertical banded gastroplasty - for severe obesity \[[@R20], [@R21]\]. Sample size was the number of patients who volunteered for the study. Patients were four males and 35 females, with a mean age of 37 years, and all had a medical evaluation prior to surgery. Mean baseline weight for all 39 patients was 292 lbs; weights were reported as absolute weight, rather than as body mass index (BMI) or percent excess weight. There was no difference in the mean weight at surgery or the percentage of females; however, the gainers were statistically significantly younger at a mean age of 32 years compared to a mean age of 39 years for the eventual weight losers (P = 0.0409). All patients underwent baseline ANS and ENS assessments prior to vertical banded gastroplasty in the years 1989 - 1992 ([Table 1](#T1){ref-type="table"}). The patients were subsequently followed for assessment of current weight. We examined over 15 years of follow-up data to investigate which relevant parameters might predict successful long-term weight loss.

###### Participants and Individual Autonomic Measurements

  Parameter                      Normal value   Student's *t*-test of means   Actual weight gainers (n = 10)   Actual weight losers (n = 29)                           
  ------------------------------ -------------- ----------------------------- -------------------------------- ------------------------------- --- --- ----- ---- ---- -----
  \% Female                                     90.00%                        89.66%                           1.0000                                                  
  Mean age at surgery (years)                   32.00                         39.04                            0.0409                                                  
  Mean weight at surgery (lbs)                  309.30                        289.34                           0.3615                                                  
  Mean EGG (cycles per min)      2.5 - 3.3      3.22                          3.31                             0.60                            8   2   20%   25   4    14%
  Mean VC (%)                    \> 80          80.40                         78.09                            0.67                            7   3   30%   20   9    31%
  Mean PAR (%)                   \> 25          35.73                         51.66                            0.11                            8   2   20%   20   9    31%
  Mean RRI (%)                   \> 33          30.90                         24.61                            0.21                            5   5   50%   8    21   72%

EGG: electrogastrogram; VC: vasoconstriction; PAR: postural adjustment ratio; RRI: R-to-R interval.

Patients who elected to have vertical banded gastroplasty underwent autonomic testing and their postoperative weights were collected over a period of 3 - 15 years with an attempt to follow the patients for up to 25 years. During the study period, they received routine care.

Autonomic testing was performed prior to surgery by measuring adrenergic, cholinergic and enteric variables. The adrenergic nervous system was measured using the PAR and VC and expressed as a percentage. The cholinergic nervous system was measured using the electrocardiogram (EKG) RRI \[[@R02]\] and also expressed as a percentage \[[@R14], [@R22]\]. Gastric electrical activity was also measured by an electrogastrogram (EGG) and expressed in cycles per minute (cpm) with a normal value being less than 3.3 cpm \[[@R22]-[@R25]\].

Adrenergic nervous system evaluation was based on capillary photoplethysmography which measures peripheral blood flow at rest, in response to postural maneuvers and cold stress. This system has been validated by catecholamine level \[[@R26]\]. Cholinergic function was measured by cardiac (EKG) RRIs, in response to deep breathing and Valsalva maneuvers. ENS function was measured by cutaneous electrogastrography and was analyzed by signal averaging; both techniques have been used previously \[[@R27]\].

Investigators following the weight changes postoperatively were blinded to the preoperative autonomic testing results. Investigators reviewed the weight changes of individual subjects and determined if the subjects were long-term weight gainers or losers. Weight gainers were defined as patients who resumed inappropriate weight gain after an early rapid weight loss (Supplementary 1, [www.gastrores.org](http://www.gastrores.org)). Weight losers continued long-term postoperative weight loss or achieved and maintained a healthy long-term body weight.

After subjects were stratified between those with continued weight gain and those with continued weight loss, the autonomic testing values were analyzed to develop a multivariate discriminate model whereby a criterion was determined from the autonomic testing to discriminate the long-term weight gainers from the long-term successful losers. The performance of the discriminant criterion was evaluated in terms of how well the model correctly classified the true gainers as gainer, as well as how many losers were correctly classified as loser.

The statistical analysis was a discriminant function analysis which can predict categorical dependent variable (in our case weight gain) by multiple independent predictor variables. In this application, the predictor variables are the various autonomic parameters clinically measured: PAR, RRI, VC, and EGG. The analysis created linear combinations of predictors and by doing so created a new latent variable for each function. Successive functions are created that maximize difference on that function, and must not be correlated with the previous function created.

Repeated attempts to obtain additional weight loss data beyond approximately 15 years did not result in a measurable number of new data points, even when patient data were available for review up to 25 years post-surgery.

Results {#s3}
=======

A committee blinded to the preoperative autonomic testing results evaluated each patient and grouped them into long-term actual weight gainers (n = 10) and long-term weight losers (n = 29) based on absolute weight loss and long-term changes over time. A weight loser either regains less than 20 pounds after reaching a nadir weight of less than 300 pounds or maintains a final weight less than 175 pounds. A weight gainer never reaches a nadir weight of less than 300 pounds, regains more than 20 pounds or attains a final weight more than 175 pounds ([Fig. 1](#F1){ref-type="fig"}) (Supplementary 1, [www.gastrores.org](http://www.gastrores.org)).

![Patient weight changes. Black lines are predicted weight gainers, green lines are those predicted to gain weight but actually lost weight, blue lines are patients predicted to lose weight, and red lines are predicted losers who actually regained.](gr-10-218-g001){#F1}

A discriminate model based on baseline measures successfully predicted ultimate weight gain in 8/10 (80%) of patients who subsequently gained weight and weight loss in 24/29 (83%) of patients who subsequently lost weight for a total correct classification of 32/39 (82%). Using linear regression, the model which was described in methods section above, used the cholinergic measure RRI, the adrenergic measures VC and PAR, and the enteric measure EGG. The values from patients were compared with normal control values as a way of constructing the model of disease state. Specific physiologic characteristics of patients who lost weight were compared to those who gained weight. Using this approach, a model that separates patients who gained weight versus those who lost was constructed.

The same model with data at 3 months postoperatively predicted weight gain in 9/10 (90%) of patients and weight loss in 24/29 (83%) of patients, for a total correct classification of 34/39 (87%) ([Table 2](#T2){ref-type="table"}).

###### Prediction of Weight Change by Model

                                                       Actual weight gain                                       Actual weight loss   Total
  ---------------------------------------------------- -------------------- ----------------------------------- -------------------- -------
  Using data obtained at baseline                                                                                                    
    Gainer model predicted weight gain                 8 (80%)              Loser model predicted weight gain   5 (17%)              13
    Gainer model predicted weight loss                 2 (20%)              Loser model predicted weight loss   24 (83%)             26
    Totals                                             10                                                       29                   
    Overall correct classification rate: 32/39 (82%)                                                                                 
  Using data 3 months postoperative data                                                                                             
    Gainer model predicted weight gain                 9 (90%)              Loser Model Predicted Weight Gain   5 (17%)              14
    Gainer model predicted weight loss                 1 (10%)              Loser Model Predicted Weight Loss   24 (83%)             25
    Totals                                             10                                                       29                   
    Overall correct classification rate: 34/39 (87%)                                                                                 

No single discriminant criterion (PAR, VC, RRI, and EGG values) alone predicted weight gain and all 39 patients had at least one abnormal criterion. For instance, of the patients who gained weight, eight had a normal EGG value and only two had abnormal values and of the patients who lost weight 25 had normal EGG values and four had abnormal values.

Discussion {#s4}
==========

Obesity has become epidemic in the United States: while in 1985 no state had an obesity prevalence greater than 14%, by 2010 every state had a prevalence of 20% or more \[[@R28]\]. Data from National Health and Nutrition Examination Survey from 2007 to 2012 show that, in the United States, 39.96% of men and 29.74% of women were overweight and 35.04% of men and 36.84% of women were obese \[[@R29]\]. Treatment success has been variable, with medications improving weight loss 3-5% over that of placebo and there has been recognition that long-term maintenance of weight loss is difficult \[[@R30]\]. There is debate about how to best define gastric obesity surgery success \[[@R31], [@R32]\]; most studies evaluating long-term success have an endpoint of only 2 years \[[@R33]\].

The strength of our study is the longevity of our data, which demonstrates the commonly observed outcome that, post-restrictive gastric surgery, weight gain occurs after the 2-year endpoint. For instance, only four of our 10 patients with long-term weight gain resumed gaining their weight at 2 years. Conversely, six of the 10 long-term weight gainers began regaining their weight after the 2-year time point, raising doubts that prior studies with a 2-year endpoint have correctly estimated the long-term success of restrictive surgery.

In this study, while no single measurement of the ANS and ENS predicted weight loss, but clustering the PAR, VC, RRI, and EGG values together as predictor variables using discriminant analysis was able to arrive at the categorical dependent variable of future weight gain and thus develop a model for future validation.

Bariatric surgery research has had variable definitions of success. Our long-term data considered a regaining of 20 pounds or a final weight of more than 175 pounds as a failure. This was done because these particular cut-offs delineated those patients who had on-going post-surgical weight gain from those with continued weight loss, or were maintaining a healthy weight. Our study was limited, as the values for patients' heights were not consistently recorded, since the focus of this study at the time of surgery was patients' actual weight loss.

By incomplete collection of patients' heights, we could not make calculations relying on heights such as ideal body weights and BMI consistently available. Prior authors have utilized patients' heights to normalize weight loss. For instance, in 1982 Reinhold reviewed prior methods of determining success after gastric bypass surgery as well as presenting his own 29 patients 1 year after surgery \[[@R34]\]. The Reinhold criteria have perhaps been misquoted as 50% excess weight loss (EWL). His paper stratified his results using two different methods, both of which relied on their ideal body weight (IBW). In the first he calculated their percent final excess weight (%FEW) (the difference of the final weight less and the IBW divided by the IBW). Weight loss after 12 months was determined to be excellent \< 25% FEW, good 26-50% FEW, fair 51-75% FEW, poor 76-100% FEW, and failure \>100% FEW. The second method Reinhold used was absolute excess final weight (AEFW) being the difference of final weight and IBW. Cut-offs for this method were excellent \< 11.4 kg, good 11.5 - 22.8 kg, fair 22.9 - 34.2 kg, poor 34.3 - 45.5 kg, and failure \> 45.7 kg. He also presented that weight regain occurred in seven of his 29 patients, but was most concerned with two patients who regained more than 20 kg and both had excess intake of alcohol.

Definitions for success after weight loss surgery have emerged which take into consideration the patient's height and have been criticized as misleading because of large variability in patients' initial BMI \[[@R32]\]. It relies on the patient's height to calculate the IBW. The difference from the patient's weight at surgery from the IBW is the excess body weight (EBW) which is used as a denominator for the percentage of excess weight loss %EWL. Subtracting the current weight from weight at surgery determines the current weight loss (WL). Dividing the WL by the EBW yields the EWL.

Since a taller height will result in a larger IBW, and eventually a smaller EBW, this smaller denominator will raise the EWL in taller individuals making it a difficult comparison between patients with variable heights and BMIs. Additionally, it is possible for a patient to regain significant weight a few years after the surgery and still have an EWL that is at goal.

The goals for EWL have varied. In the largest series of vertical banded gastroplasty patients, the EWL goal at 10 years was more than 25% of excess without another operation \[[@R20]\]. In his series, 79.37% of patients were able to have \> 25% EWL. In the gastric bypass literature, a 50% EWL has been used as a numerical goal for success. Long-term data from O'Brien and colleagues' restrictive gastric procedure patients which included a large number of patients who were followed beyond 3 years had an EWL around 50% with a 1% confidence interval \[[@R35]\]. A recent meta-analysis, which included studies with follow-up time exceeding 3 years, also compared excess weight loss and not actual weight loss \[[@R02]\].

Guidance is lacking on which patients might benefit most from weight loss surgery. A worthwhile goal would be to more accurately exclude patients that will regain weight long-term and select those who will have long-term benefits. Building a model to describe long-term weight gainers and losers is the first step; with greater numbers, the model can be refined, validated and have improved accuracy to provide patients and surgeons with a powerful tool in deciding whom should undergo a surgery.

A second question raised by the data is: if autonomic parameters predicted weight loss, could changing a patient's native values change them from long-term weight gain to continued weight loss? Enteric, adrenergic, and cholinergic measures have previously been shown to improve using gastric electrical stimulation (GES) for gastroparesis \[[@R36]\] and also after pancreas-kidney transplantation \[[@R04], [@R06], [@R9]\]. We hypothesize that if a patient's autonomic testing predicts weight gain, then GES might convert the patient's physiology into a long-term weight loss phenotype.

Conclusion {#s4a}
----------

In conclusion, we observe that long-term vertically banded gastroplasty weight gainers and losers appear to be predicted by a discriminate model based on ANS and ENS evaluation. Further research may help select patients who will benefit most from gastric bypass surgery, and provide insights on how modulation of the ANS using GES can potentially become a weight loss intervention.
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